Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio (2019 - 2021)

Zentalis Pharmaceuticals' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 0.73 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 5.53% year-over-year to 0.73; the TTM figure through Mar 2026 stood at 2.81 (up 22.13% YoY), while the FY2025 annual figure was 22.47, down 2803.38% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.73, up from 3399.36 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 0.37 in Q1 2024, with the low at 3399.36 in Q4 2025.
• The 5-year median for Interest Coverage Ratio is 1.88 (2023), against an average of 215.61.
• The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio soared 98.95% in 2022, then slumped 44225.59% in 2025.
• Zentalis Pharmaceuticals' Interest Coverage Ratio stood at 0.73 in 2022, then sank by 1354.03% to 10.61 in 2023, then grew by 27.74% to 7.67 in 2024, then plunged by 44225.59% to 3399.36 in 2025, then jumped by 99.98% to 0.73 in 2026.
• Business Quant data shows ZNTL's Interest Coverage Ratio at 0.73 in Q1 2026, 3399.36 in Q4 2025, and 2.27 in Q3 2025.